Does IDURSULFASE Cause Poor venous access? 175 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 175 reports of Poor venous access have been filed in association with IDURSULFASE (ELAPRASE). This represents 5.5% of all adverse event reports for IDURSULFASE.
175
Reports of Poor venous access with IDURSULFASE
5.5%
of all IDURSULFASE reports
18
Deaths
100
Hospitalizations
How Dangerous Is Poor venous access From IDURSULFASE?
Of the 175 reports, 18 (10.3%) resulted in death, 100 (57.1%) required hospitalization, and 4 (2.3%) were considered life-threatening.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDURSULFASE. However, 175 reports have been filed with the FAERS database.
What Other Side Effects Does IDURSULFASE Cause?
Pyrexia (524)
Product dose omission issue (450)
Inappropriate schedule of product administration (371)
Cough (263)
Infusion related reaction (241)
Pneumonia (232)
Death (222)
Dyspnoea (202)
Influenza (200)
Covid-19 (197)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which IDURSULFASE Alternatives Have Lower Poor venous access Risk?
IDURSULFASE vs IFOSFAMIDE
IDURSULFASE vs IGURATIMOD
IDURSULFASE vs ILOPERIDONE
IDURSULFASE vs ILOPROST
IDURSULFASE vs IMATINIB